Importer of Controlled Substances Application: S&B Pharma, Inc., 3077 [2020-00661]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 12 / Friday, January 17, 2020 / Notices
Federal Judiciary Building, One
Columbus Circle NE, Suite 7–300,
Washington, DC 20544, Telephone (202)
502–1820.
(Authority: 28 U.S.C. 2073)
Dated: January 14, 2020.
Rebecca A. Womeldorf,
Secretary, Committee on Rules of Practice
and Procedure, Judicial Conference of the
United States.
Notice of Lodging of Proposed
Consent Decree Under the
Comprehensive Environmental
Response, Compensation, and Liability
Act
Drug Enforcement Administration
[Docket No. DEA–573]
Importer of Controlled Substances
Application: S&B Pharma, Inc.
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before February 18, 2020. Such
persons may also file a written request
for a hearing on the application on or
before February 18, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on November 18, 2019,
S&B Pharma, Inc., dba: Norac Pharma,
405 South Motor Avenue, Azusa,
California 91702–3232 applied to be
registered as an importer of the
following basic classes of controlled
substances:
lotter on DSKBCFDHB2PROD with NOTICES
DATES:
4-Anilino-N-phenethyl-4piperidine (ANPP).
Tapentadol .......................
Schedule
8333
II
9780
II
The company plans to import the
listed controlled substances in bulk for
VerDate Sep<11>2014
18:20 Jan 16, 2020
Jkt 250001
Randall M. Stone,
Acting Assistant Section Chief,
Environmental Enforcement Section,
Environment and Natural Resources Division.
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug code
costs. Please mail your request and
payment to: Consent Decree Library,
U.S. DOJ—ENRD, P.O. Box 7611,
Washington, DC 20044–7611.
Please enclose a check or money order
for $5.25 (25 cents per page
reproduction cost) payable to the United
States Treasury.
BILLING CODE 4410–09–P
BILLING CODE 2210–55–P
Controlled substance
Dated: December 19, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–00661 Filed 1–16–20; 8:45 am]
[FR Doc. 2020–00716 Filed 1–16–20; 8:45 am]
ACTION:
the manufacture of controlled
substances for distribution to its
customers.
3077
On January 13, 2020, the Department
of Justice lodged a proposed Consent
Decree with the United States District
Court for the Southern District of Ohio
in the lawsuit entitled United States v.
Dayton Industrial Drum, Inc., et al.,
Civil Action No. 3:16–cv–232–WHR.
In June 2016, the United States filed
suit against Dayton Industrial Drum,
Inc. and Sunoco, Inc. (‘‘Sunoco’’) under
the Comprehensive Environmental
Response, Compensation, and Liability
Act for the recovery of response costs
incurred at the Lammers Barrel
Superfund Site in Beavercreek, Ohio
(the ‘‘Site’’). The Consent Decree
resolves the liability of Sunoco and the
alleged liability of its indemnitor,
Carboline Company, at the Site for a
total of $1,300,000.
The publication of this notice opens
a period for public comment on the
proposed Consent Decree. Comments
should be addressed to the Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States v. Dayton
Industrial Drum, Inc., D.J. Ref. No. 90–
11–3–07706/3. All comments must be
submitted no later than thirty (30) days
after the publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
By mail .........
During the public comment period,
the proposed Consent Decree may be
examined and downloaded at this
Justice Department website: https://
www.justice.gov/enrd/consent-decrees.
We will provide a paper copy of the
proposed Consent Decree upon written
request and payment of reproduction
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
[FR Doc. 2020–00730 Filed 1–16–20; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Office of Justice Programs
[OJP (OJJDP) Docket No. 1771]
Meeting of the Federal Advisory
Committee on Juvenile Justice
Office of Juvenile Justice and
Delinquency Prevention, Department of
Justice.
ACTION: Notice of meeting.
AGENCY:
The Office of Juvenile Justice
and Delinquency Prevention is updating
its meeting notice, published on
December 20, 2019, because it has rescheduled the meeting of the Federal
Advisory Committee on Juvenile Justice
(FACJJ), that had been scheduled for
January 7, 2020, but was postponed due
to inclement weather causing early
closure of Washington, DC-area federal
offices on the scheduled meeting date.
DATES: The re-scheduled meeting date is
February 5, 2020 at 2–3 p.m. ET.
ADDRESSES: The meeting will take place
remotely via webinar.
FOR FURTHER INFORMATION CONTACT: Visit
the website for the FACJJ at
www.facjj.ojp.gov or contact Elizabeth
Wolfe, Designated Federal Official
(DFO), OJJDP, by telephone at (202)
598–9310, email at elizabeth.wolfe@
ojp.usdoj.gov; or Maegen Barnes, Senior
Program Manager/Federal Contractor, by
telephone (732) 948–8862, email at
maegen.barnes@bixal.com, or fax at
(866) 854–6619. Please note that the
above phone/fax numbers are not toll
free.
SUPPLEMENTARY INFORMATION: The
Federal Advisory Committee on
Juvenile Justice (FACJJ), established
pursuant to Section 3(2)A of the Federal
Advisory Committee Act (5 U.S.C.
App.2), will meet to carry out its
advisory functions under Section
223(f)(2)(C–E) of the Juvenile Justice and
Delinquency Prevention Act of 2002.
The FACJJ is composed of
representatives from the states and
SUMMARY:
E:\FR\FM\17JAN1.SGM
17JAN1
]]>Agencies
[Federal Register Volume 85, Number 12 (Friday, January 17, 2020)]
[Notices]
[Page 3077]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-00661]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-573]
Importer of Controlled Substances Application: S&B Pharma, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before February 18, 2020.
Such persons may also file a written request for a hearing on the
application on or before February 18, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on November 18, 2019, S&B Pharma, Inc., dba: Norac
Pharma, 405 South Motor Avenue, Azusa, California 91702-3232 applied to
be registered as an importer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
4-Anilino-N-phenethyl-4-piperidine 8333 II
(ANPP).
Tapentadol............................ 9780 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances in
bulk for the manufacture of controlled substances for distribution to
its customers.
Dated: December 19, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-00661 Filed 1-16-20; 8:45 am]
BILLING CODE 4410-09-P
